Evidence map›Paper›PMID 24648995›Full record

ArticleBiomedical reports2013

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

Jun Lu, Shan Jiang, Song Ye, Yun Deng, Shuai Ma, Chao-Pin Li

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jun LuDepartment of Pathogen Biology and Immunology, School of Medicine, Anhui University of Science and Technology, P.R. China.
Shan JiangDepartment of Mining Engineering, Huainan Vocational and Technical College, Huainan, Anhui 232001, P.R. China.
Song YeDepartment of Pathogen Biology and Immunology, School of Medicine, Anhui University of Science and Technology, P.R. China.
Yun DengDepartment of Pathogen Biology and Immunology, School of Medicine, Anhui University of Science and Technology, P.R. China.
Shuai MaDepartment of Pathogen Biology and Immunology, School of Medicine, Anhui University of Science and Technology, P.R. China.
Chao-Pin LiDepartment of Pathogen Biology, Bengbu Medical College, Wuhu, Anhui 241002, P.R. China.
Anhui University of Science and Technology · CNBengbu Medical College · CNHuainan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis is considered one of the most important neglected tropical diseases and remains a major public health problem in endemic countries. Toll-like receptor (TLR) ligands have been investigated as potential vaccine adjuvants for tumor and virus immunotherapy. However, few TLR ligands affecting schistosoma vaccines have been characterized. In this study, we evaluated a TLR9 ligand (CpG oligodeoxynucleotide 1826, CpG) as an adjuvant for a partially protective DNA vaccine encoding a 26-kDa glutathione S-transferase of

Indexed as

CpG oligodeoxynucleotide ligandpVAX1-Sj26GSTvaccine

Identifiers

PMID24648995
PMCPMC3916974
OpenAlexW2095194801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.